Literature DB >> 27645108

Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcoma.

Elizabeth B Andrews1, Alicia Gilsenan2, Kirk Midkiff2, David Harris2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27645108     DOI： 10.1016/j.annepidem.2016.08.011

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN： 1047-2797            Impact factor:   3.797


× No keyword cloud information.
  4 in total

1.  Laparoscopic Revision of Bariatric Surgeries in Two Patients with Severe Resistant Hypocalcemia After Endocrine Cervical Surgery.

Authors:  Magda Zaarour; Ramona Zaharia; Marion Bretault; Christel Jublanc; Capucine De Marcellus; Jean-Luc Bouillot; Hervé Lefebvre; Jean-Michel Oppert; Judith Aron-Wisnewsky; Marie-Laure Raffin-Sanson
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Improved estimation of the cumulative incidence of rare outcomes.

Authors:  David Benkeser; Marco Carone; Peter B Gilbert
Journal:  Stat Med       Date:  2017-07-02       Impact factor: 2.373

Review 3.  Bone modeling, remodeling, and skeletal health in children and adolescents: mineral accrual, assessment and treatment.

Authors:  Chiara Maggioli; Stefano Stagi
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-03-31

4.  The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.

Authors:  A Gilsenan; A Harding; N Kellier-Steele; D Harris; K Midkiff; E Andrews
Journal:  Osteoporos Int       Date:  2018-07-05       Impact factor: 4.507
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.